Jushi Holdings Inc. is a vertically integrated cannabis company involved in the cultivation, processing, and retail of medical and adult-use products. While it boasts a solid gross margin of 44.2% and an EBITDA margin of 15.2%, concerns arise from a negative net margin of -10.3% and low liquidity ratios, with a current ratio of 0.83 and a quick ratio of 0.46. The stock's recent 9.59% increase may not fully reflect its financial health, given the overall low score of 29/100, indicating potential volatility and risk for investors.
Loading financial metrics...
Company posted a loss of $-66.4M over the last year, representing 24.4% of revenue.
Debt of $293.9M is 8.8x the company's cash position of $33.3M.
Both gross margin (+2.2pp) and operating margin (+2.0pp) are expanding simultaneously, indicating the company is scaling profitably.
Operating cash flow surged 42.4% YoY, indicating strong cash generation capability.
Free cash flow increased 42.4% YoY, enhancing capital allocation optionality.
Valuation, risk assessment, competitive positioning, and key insights — all in one report.
Other Drug Manufacturers - Specialty & Generic companies of a similar size
Based on 2026-Q2 (June 30, 2026)